55 Tirzepatide Clinics in New Jersey

What is Tirzepatide?

Tirzepatide is the active ingredient in Mounjaro (for type 2 diabetes) and Zepbound (for weight loss). It is the first medication that targets two hunger hormones at once: GIP and GLP-1. By activating both, it produces stronger weight loss and blood sugar control than older GLP-1-only medications like semaglutide. In the largest clinical trial, people on the highest dose lost an average of 22.5% of their body weight, more than any other FDA-approved weight loss drug.

Brand names

Tirzepatide is available as Mounjaro, Zepbound, manufactured by Eli Lilly.

Expected weight loss

In the main weight loss trial, people on tirzepatide 15 mg lost an average of 22.5% of their body weight over 72 weeks (about 17 months). At 10 mg, the average was 21.4%. Over a third of people on the highest dose lost 25% or more. For a 200-pound person, 22.5% is roughly 45 pounds.

Cost in New Jersey

Without insurance, Tirzepatide typically costs $1,000-$1,200/month (Mounjaro), $1,000-$1,100/month (Zepbound). With insurance, costs range from $25-$200/month (varies by plan). Compounded options may be available at $250-$550/month.

Savings programs: Eli Lilly offers the Zepbound Savings Card (commercially insured patients may pay as low as $25/month) and the LillyDirect platform for direct-to-patient delivery.